JW Group Announces Call for Nominations for the 11th Seongcheon Award... Until the 10th of Next Month

[Asia Economy Reporter Myunghwan Lee] The Jungwoo Academic Welfare Foundation, a public interest foundation of JW Group, announced on the 8th that it is accepting nominations for candidates for the 11th Seongcheon Award.

The Seongcheon Award was established in 2012 to honor the 'respect for life' spirit of the late Seongcheon Lee Gi-seok, the founder of JW Jungwoo Pharmaceutical, and to discover medical professionals who serve as role models in society. This year marks the 11th anniversary of the award.

The nomination period for this year's Seongcheon Award runs until the 10th of next month. Candidates can download the nomination form from the foundation's website, fill out their achievements, and submit it via email or postal mail.

To ensure fair evaluation, the Seongcheon Award Committee, composed of medical professionals from various regions and fields, conducts a three-stage review process: first document screening, second on-site evaluation, and third comprehensive assessment. They evaluate the applicants' achievements and contributions from multiple perspectives before selecting the award candidates. The final awardees are decided after a board of directors' review.

Eligibility for the Seongcheon Award requires medical professionals licensed by the Minister of Health and Welfare (including doctors, dentists, Korean medicine doctors, nurses, and midwives). Award recipients receive a prize of 100 million KRW and a plaque. The award ceremony is scheduled to be held in September.

Lee Seong-nak, chairman of the Seongcheon Award Committee, said, "We will support medical professionals who transcend nationality and dedicate themselves to alleviating the suffering of neighbors afflicted by disease and poverty by practicing true medical skills to improve the quality of healthy life."

Seongcheon Lee Gi-seok founded Joseon Jungwoo Pharmaceutical (now JW Jungwoo Pharmaceutical) in 1945 and operated the company with the philosophy that "if a medicine is necessary for the health of the people, it must be produced." To fulfill corporate social responsibility, he devoted his life to laying the foundation of the domestic therapeutic pharmaceutical industry, including domestic production of intravenous fluids, which were entirely imported at the time, in 1959.

This content was produced with the assistance of AI translation services.